S&P Futures
5,884.00 -12.25 (-0.21%) Dow Futures
43,098.00 -79.00 (-0.18%) Nasdaq Futures
20,460.00 -59.50 (-0.29%) Russell 2000 Futures
2,247.40 -8.10 (-0.36%) Crude Oil
70.50 -0.06 (-0.09%) Gold
2,750.20 +11.30 (+0.41%)
Clever Leaves Holdings Inc. (CLVR)
| Previous Close | 0.0000 |
| Open | 1.0000 |
| Bid | 2.4000 x 21500 |
| Ask | 2.5000 x 0 |
| Day's Range | 1.0000 - 1.0000 |
| 52 Week Range | 0.0001 - 5.8899 |
| Volume | |
| Avg. Volume | 202 |
| Market Cap | 526 |
| Beta (5Y Monthly) | 15.08 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -12.6300 |
| Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireClever Leaves Announces Voluntary Delisting and SEC Deregistration
TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, today announced that its Board of Directors (the “Board”) determined to voluntarily delist its common shares, without par value (the “common shares”) and warrants, each exercisable for 1/30th common share at an exercise price of $11.50 (the “Warrants” and together with the common shares, the “Securities”) from The Nasda
- GlobeNewswire
Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
- 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue - - Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for the Full Year - - Completed Sale of Non-Cannabinoid Herbal Brands Business on March 21, 2024 for $8.02 Million, Including $7.02 Million in Cash Paid at Closing - TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”)
